CVE-2026-60007In Eclipse Milo versions 0.6.0 through 1.1.4, username-token processing returns distinguishable errors for invalid RSA PKCS#1 v1.5 padding and other authentication failures, allowing an on-path attac…
Updated under an hour ago ()
Does this affect you?
It affects Eclipse Foundation Eclipse Milo and 1 other product. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
In Eclipse Milo versions 0.6.0 through 1.1.4, username-token processing returns distinguishable errors for invalid RSA PKCS#1 v1.5 padding and other authentication failures, allowing an on-path attacker who captures a victim's `Basic128Rsa15`-encrypted username token to use repeated unauthenticated `ActivateSession` requests as a padding oracle, recover the victim's password, and authenticate with the recovered credentials.
- CVSS
- 9.1 CRITICAL (v4.0, CNA)CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N
- Weakness (CWE)
- CWE-204
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- eclipse
- NVD analysis
- Analyzed
- Record last updated
- Aug 4, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
Eclipse Foundation Eclipse Milo eclipse_foundation:eclipse_milo (from the name) | from 0.6.0 through 1.1.4 | CNA record |
eclipse milo eclipse:milo | from 0.6.0 before 1.1.5 | NVD |
References
- https://github.com/eclipse-milo/milo/commit/db59fae993a3a1bc66fffc8a2796d444b40285fbpatch
- https://gitlab.eclipse.org/security/vulnerability-reports/-/work_items/598issue-tracking, vendor-advisory
- https://gitlab.eclipse.org/security/cve-assignment/-/work_items/183issue-tracking, patch, vendor-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.